Browsing Tag
ImExHS Limited
3 posts
IMEXHS (ASX: IME) EBITDA jumps 311% as A$4.4m contracted backlog awaits billing
IMEXHS has lifted first-half underlying EBITDA more than fourfold while building A$4.4 million of contracted annual recurring revenue that had not yet begun billing at June 30. The next test is conversion, particularly as its Aquila+ agentic AI platform moves into production and Colombian healthcare collections remain a working-capital constraint.
IMEXHS (ASX: IME) expands Mexico radiology software footprint with 20-site Zacatecas hospital contract
IMEXHS wins a Mexico public hospital tender for Aquila+, adding new ARR and AI radiology momentum. Find out what it means for ASX: IME today!
ImExHS stock edges higher as new Colombia oncology deal marks A$1.4m ARR breakthrough
ImExHS (ASX: IME) secures A$1.4M Colombia oncology contract with Oncolife. Can SaaS imaging and AI radiology services restore investor confidence?